FindMyKOL
Clinical trialNCT05887557RecruitingInterventional

Multidisciplinary Low-Barrier and Mobile HIV Care to Improve Retention and Viral Suppression: Stakeholder-Engaged Design and Evaluation

NCT05887557 is an interventional trial sponsored by University of California, San Francisco. As of 21 Nov 2026, it is recruiting participants. It studies HIV. The registry lists an enrollment of 400 participants at 5 sites in 1 country. The registry lists a start date of 16 May 2024 and a primary completion date of 31 Mar 2027.

View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT05887557
FieldValue
Registry IDNCT05887557
StatusRecruiting
Study typeInterventional trial
Lead sponsorUniversity of California, San Francisco
Enrollment400
Registered sites5
Countries1
ConditionsHIV
Start16 May 2024
Primary completion31 Mar 2027
Study completion31 Mar 2027
Last update posted24 Feb 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the implementation and effectiveness of a flexible, multidisciplinary, integrated drop-in/mobile HIV care approach for people living with HIV (PLH) who are not well engaged in current care systems (i.e. scheduled HIV primary care visits). The hybrid type 2 implementation-effectiveness study involves a set of implementation strategies to support implementation of the integrated drop-in/mobile HIV care approach (i.e. the evidence-informed clinical intervention) at four diverse sites in San Francisco and Alameda counties in California. Sites include an academic clinic located at a public hospital (Ward 86) and a needle exchange site (San Francisco AIDS Foundation Syringe Access Site) in San Francisco and two Federally Qualified Health Centers serving diverse patient populations in Alameda County (Trust and La Clínica). The evidence-informed clinical intervention consists of four key components: 1) active referral to care sites; 2) drop-in, multidisciplinary HIV primary care; 3) mobile HIV care; and 4) staged escalation/de-escalation of care level as needed. The study will use RE-AIM to guide evaluation, with coprimary outcomes of Reach and HIV viral suppression, and mixed methods to assess intervention Adoption, Implementation, and Maintenance. The study draws on the CFIR framework to assess site-specific implementation determinants before and after the study period. The study will undertake micro-costing using a uniform cost data collection protocol to quantify the resources needed to carry out intervention activities.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States5 sites, 5 recruiting
  • la Clinica de la Raza, Inc

    Oakland

    Jennifer Huggans-Zapeta, NP
    Recruiting
  • Lifelong Medical Care

    Oakland

    Kevin Critchlow, MD
    Recruiting
  • San Francisco Aids Foundation

    San Francisco

    Jorge Roman, NP
    Recruiting
  • San Francisco Department of Public Health Maria X Martinez Clinic

    San Francisco

    Stephen Matzat, MD
    Recruiting
  • Zuckerberg San Francisco General Hospital

    San Francisco

    Recruiting

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCalifornia: 5 sites, 5 recruitingCA5NevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT05887557

Each answer restates registry values shown on this page.

What is NCT05887557?

NCT05887557 is an interventional trial sponsored by University of California, San Francisco. It studies HIV.

Is NCT05887557 recruiting?

As of 21 Nov 2026, it is recruiting participants. 5 of its 5 sites list their own status as recruiting.

Who leads NCT05887557?

The registry names Katerina Christopoulos, MD, MPH (principal investigator, University of California, San Francisco) and Matthew Hickey, MD (principal investigator, University of California, San Francisco) as overall officials.

Where does NCT05887557 run?

The registry lists 5 sites in 1 country. Every site with a stated country is in one country: United States.

When is NCT05887557 expected to complete?

The registry lists a primary completion date of 31 Mar 2027 and a study completion date of 31 Mar 2027. The sponsor last updated the record on 24 Feb 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.